Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and KoreaMichinori Ogura, Kensei Tobinai, Youko Suehiro et al.|Japanese Journal of Clinical Oncology|2020Cited by 15
Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphomaEiju Negoro, Kensei Tobinai, Takahiro Yamauchi et al.|Journal of the Japan Society of the Reticuloendothelial System|2023Cited by 3